Paul Bolno - 04 Feb 2025 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role: President and CEO, Director
Signature: /s/ Paul B. Bolno
Issuer symbol: WVE
Transactions as of: 04 Feb 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Feb 2025, 20:00:07 UTC
Previous filing: 27 Nov 2024
Next filing: 07 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WVE	Ordinary Shares	Award	$0	+121,000	+56%	$0.000000	338,351	04 Feb 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WVE	Share Option (right to buy)	Award	$0	+1,000,000		$0.000000	1,000,000	04 Feb 2025	Ordinary Shares	1,000,000	$11.74	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029.
F2	The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029.